Recent insider trading activity from King Michael, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 21, 2024 | SAB Biotherapeutics, Inc. | $SABS | King Michael | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 5,521,487 | 9999.99% | 2.08% |